Why the study?
Does low-dose acetylsalicylic acid alter hemodynamics in the fetal ductus arteriosus in pregnant women?
Does low-dose acetylsalicylic acid alter hemodynamics in the fetal ductus arteriosus in pregnant women?
Low-dose ASA administration during pregnancy does not appear to adversely alter fetal ductus arteriosus hemodynamics.
Answers are grounded in this paper and cite their sources.
Low-dose ASA may alter fetal ductus arteriosus hemodynamics; hypothesis-generating and should not yet change practice.
AIM: Acceleration-time/ejection-time ratio (At/Et ratio) of Doppler waveform is an established hemodynamic parameters that reflect proximal stenosis. Using this parameter, we evaluated whether perinatal low-dose acetylsalicylic acid (ASA) therapy could alter hemodynamics in the ductus arteriosus. METHODS: Pulse Doppler measurements of the fetal ductus arteriosus were performed longitudinally from 20 to 37 gestational weeks in 106 healthy pregnant women (controls) and 65 pregnant women taking daily low-dose ASA (80 or 100 mg/day) because of a history of recurrent pregnancy loss. The At/Et ratio, pulsatility index (PI), and peak systolic velocity were evaluated and statistically analyzed. RESULTS: The At/Et ratio significantly increased with gestational age in both the ASA group (r = 0.54) and the control group (r = 0.35), while the PI did not. Median peak systolic velocities also increased with gestational age in both the ASA group (r = 0.39) and the control group (r = 0.31). No significant differences in At/Et ratio, PI, or peak systolic velocity were observed between the ASA group and the control group. CONCLUSION: Administration of low-dose ASA during pregnancy did not appear to alter hemodynamics in the fetal ductus arteriosus.
No takes yet. Share an insight, caveat, or question.
Miyazaki et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: